Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: New Haven CT, Trumbull CT, Mineola NY, New York NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Sherbrooke, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca
Sex: All
Age: 40+
Code: NCT07652658
Phase 2, Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for
Irritable Bowel Syndrome
Location: Boston MA, North Massapequa NY, Richmond Hill NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07519395
Phase 2, Recruiting
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
for
Asthma
Location: Wyomissing PA, Burke VA, Lake Worth FL, Aventura FL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 12+
Code: NCT07456033
Phase 3, Recruiting
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
for
Limbal Stem Cell Deficiency
Location: South Dartmouth MA, Rockville Centre NY,
Sponsor: Claris Biotherapeutics, Inc.
Sex: All
Age: 12 - 70+
Code: NCT07636590
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
for
Liver Transplant
Location: New York NY, Washington D.C. DC, Pittsburgh PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 3 - 13
Code: NCT07549503
Phase 2, Recruiting
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
for
Metastatic Pancreatic Ductal Adenocarcinoma, PDAC
Location: New Haven CT, Philadelphia PA, Fairfax VA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07490301
Phase 2, Phase 3, Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
for
Colitis, Ulcerative
Location: London, Kentville, New York NY, Montreal, Richmond VA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07577856
Phase 3, Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn Disease
Location: London, Halifax, Kentville, New York NY, Montreal,
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Scarborough ME, Worcester MA, New York NY, Camden NJ,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer